Oklo Stock Surges 261% in 2025 as Nuclear Energy Demand Grows
Oklo's stock has skyrocketed 261% in the first seven months of 2025, fueled by investor enthusiasm for nuclear energy and small modular reactor (SMR) technology. The company's recent acquisition of Atomic Alchemy marks a strategic pivot into radioisotope production, with revenue generation expected by mid-2026.
Oklo plans to submit a license application for its Versatile Isotope Production Reactor in 2025, targeting operational status by 2028. The MOVE aligns with Research Nester's bullish projections for the radioisotopes market, positioning Oklo as a multifaceted player in the evolving energy sector.